Since its discovery in 2009, Candida auris has emerged as a serious global health concern due to its drug resistance.

In a recent Science Advances study, scientists have developed a novel nanozyme-probiotic combination therapy for Candida vaginitis, which shows potency in killing the causative pathogen, restoring ...

Successful management of denture-associated candidiasis relies heavily on mechanical disinfection rather than pharmacologic ...

Invasive Candida infections remain an important cause of morbidity and mortality, especially in hospitalized and immunocompromised or critically ill patients. A limited number of antifungal agents ...

The FDA’s advisory committee on antimicrobial drugs on Jan. 25 recommended rezafungin be approved to treat candidemia and invasive candidiasis in adults with limited or no alternative treatment option ...

Researchers discovered a possible weakness in the deadly hospital superbug C. auris that could lead to new treatments for the ...

A recent study published in the journal Biomedicines aimed to determine the antifungal tolerance of Candida auris (C. auris) to all three classes of antifungal drugs commonly used to treat invasive ...

Experts are warning about a multi-drug resistant fungus known as a “superbug,” which has been detected in Connecticut.

Candida auris, a multi-drug resistant yeast-like fungus, is emerging across the state, posing significant health challenges, ...

Candida auris is a fast-spreading, drug-resistant fungus threatening hospitals worldwide, with limited treatments and urgent ...